Study title: PRIMACORP: Prophylactic Intravenous use of milrinone after cardiac operation in Pediatrics - Sanofi-Synthelabo Inc - August 2001
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Cardiovascular Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: MILRINONE | |||||
| ATC code: C01CE02 | |||||
| Document link: PRIMACORP.pdf | |||||
| Document date: 2011-08-11 | |||||
| Study number: PRIMACORP | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | Y | Y | Y | - | |